{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:21:51Z","timestamp":1792120911361,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42770-021-00655-4","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T02:02:36Z","timestamp":1636768956000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus"],"prefix":"10.1007","volume":"53","author":[{"given":"Amira M.","family":"El-Ganiny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-9223","authenticated-orcid":false,"given":"Amany I.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Shaldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham A.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"key":"655_CR1","doi-asserted-by":"publisher","first-page":"DD05","DOI":"10.7860\/JCDR\/2015\/13856.6378","volume":"9","author":"K Padmavathy","year":"2015","unstructured":"Padmavathy K, Praveen S, Madhavan R, Krithika N, Kiruthiga AJ (2015) Clinico-microbiological investigation of catheter associated urinary tract infection by Enterococcus faecalis: vanA genotype. Clin Diagn Res 9:DD05\u2013DD06. https:\/\/doi.org\/10.7860\/JCDR\/2015\/13856.6378","journal-title":"Clin Diagn Res"},{"key":"655_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603\u2013661. https:\/\/doi.org\/10.1128\/CMR.00134-14","journal-title":"Clin Microbiol Rev"},{"key":"655_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22203\/eCM.v004a04","volume":"4","author":"L Harris","year":"2002","unstructured":"Harris L, Foster S, Richards R (2002) An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater 4:39\u201360","journal-title":"Eur Cell Mater"},{"key":"655_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HFL Wertheim","year":"2005","unstructured":"Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van BelKum A, Verbrugh HA, Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infect Dis 5:751\u2013762","journal-title":"The Lancet Infect Dis"},{"key":"655_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520\u2013532","journal-title":"N Engl J Med"},{"key":"655_CR6","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1128\/JCM.43.5.2384-2390.2005","volume":"43","author":"A Holmes","year":"2005","unstructured":"Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM (2005) Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43:2384\u20132390","journal-title":"J Clin Microbiol"},{"key":"655_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/CMR.13.1.16","volume":"13","author":"MM Dinges","year":"2000","unstructured":"Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16\u201334","journal-title":"Clin Microbiol Rev"},{"key":"655_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1271\/bbb.68.981","volume":"68","author":"J Kaneko","year":"2004","unstructured":"Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures pore-forming mechanism organization of the genes. Biosci Biotechnol Biochem 68:981\u20131003","journal-title":"Biosci Biotechnol Biochem"},{"key":"655_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrmicro1289","volume":"3","author":"TJ Foster","year":"2005","unstructured":"Foster TJ (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3:948\u2013958","journal-title":"Nat Rev Microbiol"},{"key":"655_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1248\/bpb.35.48","volume":"35","author":"K Sakai","year":"2012","unstructured":"Sakai K, Koyama N, Fukuda T, Mori Y, Onaka H, Tomoda H (2012) Search method for inhibitors of Staphyloxanthin production by methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 35:48\u201353","journal-title":"Biol Pharm Bull"},{"key":"655_CR11","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/IAI.68.3.1048-1053.2000","volume":"68","author":"C Vuong","year":"2000","unstructured":"Vuong C, Gotz F, Otto M (2000) Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun 68:1048\u20131053","journal-title":"Infect Immun"},{"key":"655_CR12","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1172\/JCI20442","volume":"112","author":"JM Yarwood","year":"2003","unstructured":"Yarwood JM, Schlievert PM (2003) Quorum sensing in Staphylococcus infections. J Clin Invest 112:1620\u20131625. https:\/\/doi.org\/10.1172\/JCI20442","journal-title":"J Clin Invest"},{"key":"655_CR13","doi-asserted-by":"publisher","first-page":"601905","DOI":"10.4061\/2011\/601905","volume":"2011","author":"J Bien","year":"2011","unstructured":"Bien J, Sokolova O, Bozko PP (2011) Characterization of virulence factors of Staphylococcus aureus: novel function of known virulence factors that are implicated in activation of airway epithelial proinflammatory response. J Pathog 2011:601905. https:\/\/doi.org\/10.4061\/2011\/601905","journal-title":"J Pathog"},{"key":"655_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1084\/jem.20050846","volume":"202","author":"GY Liu","year":"2015","unstructured":"Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF et al (2015) Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202:209\u2013215","journal-title":"J Exp Med"},{"key":"655_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/AAC.00680-10","volume":"55","author":"NN Mishra","year":"2011","unstructured":"Mishra NN, Liu GY, Yeaman MR, Nast CC, Proctor RA, McKinnell J et al (2011) Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother 55:526\u2013531","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1128\/JB.00789-07","volume":"189","author":"JM Yarwood","year":"2007","unstructured":"Yarwood JM, Paquette KM, Tikh LB, Volper EM, Greenberg EP (2007) Generation of virulence factor variants in Staphylococcus aureus biofilms. J Bacteriol 189:7961\u20137967","journal-title":"J Bacteriol"},{"key":"655_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1039\/C9MD00044E","volume":"10","author":"KM Craft","year":"2019","unstructured":"Craft KM, Nguyen JM, Berg LJ, Townsend SD (2019) Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype. Medchemcomm 10:1231\u20131241","journal-title":"Medchemcomm"},{"key":"655_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S et al (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763\u20131771. https:\/\/doi.org\/10.1001\/jama.298.15.1763","journal-title":"JAMA"},{"key":"655_CR19","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/cid\/cix640","volume":"65","author":"EY Klein","year":"2017","unstructured":"Klein EY, Mojica N, Jiang W, Cosgrove SE, Septimus E, Morgan DJ et al (2017) Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States 2010\u20132014. Clin Infect Dis 65:1921\u20131923. https:\/\/doi.org\/10.1093\/cid\/cix640","journal-title":"Clin Infect Dis"},{"key":"655_CR20","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1517\/14656566.2010.511614","volume":"11","author":"S Pichereau","year":"2010","unstructured":"Pichereau S, Rose WE (2010) Invasive community-associated MRSA infections: epidemiology and antimicrobial management. Expert Opin Pharmacother 11:3009\u20133025. https:\/\/doi.org\/10.1517\/14656566.2010.511614","journal-title":"Expert Opin Pharmacother"},{"key":"655_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijmm.2013.02.005","volume":"303","author":"JA Lindsay","year":"2013","unstructured":"Lindsay JA (2013) Hospital-associated MRSA and antibiotic resistance-what have we learned from genomics? Int J Med Microbiol 303:318\u2013323. https:\/\/doi.org\/10.1016\/j.ijmm.2013.02.005","journal-title":"Int J Med Microbiol"},{"key":"655_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijmm.2013.02.007","volume":"303","author":"M Otto","year":"2013","unstructured":"Otto M (2013) Community-associated MRSA: what makes them special? Int J Med Microbiol 303:324\u2013330. https:\/\/doi.org\/10.1016\/j.ijmm.2013.02.007","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"655_CR23","doi-asserted-by":"publisher","first-page":"e00020","DOI":"10.1128\/CMR.00020-18","volume":"31","author":"S Lakhundi","year":"2018","unstructured":"Lakhundi S, Zhang K (2018) Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev 31(4):e00020-e118. https:\/\/doi.org\/10.1128\/CMR.00020-18","journal-title":"Clin Microbiol Rev"},{"key":"655_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"A Hassoun","year":"2017","unstructured":"Hassoun A, Linden PK, Friedman B (2017) Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care 21:211. https:\/\/doi.org\/10.1186\/s13054-017-1801-3","journal-title":"Crit Care"},{"key":"655_CR25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1090956","volume":"302","author":"LM Weigel","year":"2003","unstructured":"Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE et al (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569\u20131571","journal-title":"Science"},{"key":"655_CR26","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10:S122\u2013S129. https:\/\/doi.org\/10.1038\/nm1145","journal-title":"Nat Med"},{"key":"655_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro1818","volume":"6","author":"L Cegelski","year":"2008","unstructured":"Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6:17\u201327. https:\/\/doi.org\/10.1038\/nrmicro1818","journal-title":"Nat Rev Microbiol"},{"key":"655_CR28","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1169920","volume":"324","author":"MS Boguski","year":"2009","unstructured":"Boguski MS, Mandl KD, Sukhatme VP (2009) Drug discovery. Repurposing with a difference. Science 324:1394\u20131395","journal-title":"Science"},{"key":"655_CR29","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2174\/1381612823666170209154745","volume":"23","author":"W Younis","year":"2017","unstructured":"Younis W, AbdelKhalek A, Mayhoub AS, Seleem MN (2017) In vitro screening of an FDA-approved library against ESKAPE pathogens. Curr Pharm Des 23:2147\u20132157. https:\/\/doi.org\/10.2174\/1381612823666170209154745","journal-title":"Curr Pharm Des"},{"key":"655_CR30","first-page":"301","volume":"23","author":"WL Deng","year":"2010","unstructured":"Deng WL (2010) Observation of curative effects of omeprazole in treating 53 cases of chronic superficial gastritis. J Med Theory Pract 23:301\u2013302","journal-title":"J Med Theory Pract"},{"key":"655_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2340\/00015555-0840","volume":"90","author":"M Alsterholm","year":"2010","unstructured":"Alsterholm M, Karami N, Faergemann J (2010) Antimicrobial activity of topical skin pharmaceuticals \u2013 an in vitro study. Acta Derm Venereol 90:239\u2013245","journal-title":"Acta Derm Venereol"},{"key":"655_CR32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1517\/14656566.2012.687047","volume":"13","author":"GE Pi\u00e9rard","year":"2012","unstructured":"Pi\u00e9rard GE, Hermanns-L\u00ea T, Delvenne P, Pi\u00e9rard-Franchimont C (2012) Miconazole, a pharmacological barrier to skin fungal infections. Expert opin Pharmacother 13:1187\u20131194","journal-title":"Expert opin Pharmacother"},{"key":"655_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/vde.12357","volume":"27","author":"SM Clark","year":"2016","unstructured":"Clark SM, Loeffler A, Schmidt VM, Chang Y, Wilson A, Timofte D, Bond R (2016) Interaction of chlorhexidine with tris-EDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions. Vet Dermatol 27:340\u2013345","journal-title":"Vet Dermatol"},{"key":"655_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/myc.12620","volume":"60","author":"P Nenoff","year":"2017","unstructured":"Nenoff P, Koch D, Kr\u00fcger C, Drechsel C, Mayser P (2017) New insights on the antibacterial efficacy of miconazole in vitro. Mycoses 60:552\u2013557","journal-title":"Mycoses"},{"key":"655_CR35","volume-title":"Basic laboratory procedures in clinical bacteriology","author":"J Vandepitte","year":"2003","unstructured":"Vandepitte J, Verhaegen J, Engbaek K, Rohner P, Piot R, Heuck CC (2003) Basic laboratory procedures in clinical bacteriology, 2nd edn. World Health Organization, Geneva","edition":"2"},{"key":"655_CR36","unstructured":"Clinical Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing (2015). CLSI document M100-S-25. Wayne, PA."},{"key":"655_CR37","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","volume":"50","author":"Y Nalca","year":"2006","unstructured":"Nalca Y, J\u00e4nsch L, Bredenbruch F, Geffers R, Buer J, H\u00e4ussler S (2006) Quorum sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50:1680\u20131688. https:\/\/doi.org\/10.1128\/AAC.50.5.1680-1688.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR38","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.46.6.1914-1920.2002","volume":"46","author":"CF Carson","year":"2002","unstructured":"Carson CF, Mee BJ, Riley TV (2002) Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 46:1914\u20131920","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR39","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/molecules15031679","volume":"15","author":"H Xiang","year":"2010","unstructured":"Xiang H, Qiu JZ, Wang DC, Jiang Y, Xia L, Deng X (2010) Influence of magnolol on the secretion of \u03b1-toxin by Staphylococcus aureus. Molecules 15:1679\u20131689. https:\/\/doi.org\/10.3390\/molecules15031679","journal-title":"Molecules"},{"key":"655_CR40","first-page":"628","volume":"4","author":"P Vijayaraghavan","year":"2013","unstructured":"Vijayaraghavan P, Vincent SGP (2013) A simple method for the detection of protease activity on agar plates using bromocresolgreen dye. J Biochem Tech 4:628\u2013630","journal-title":"J Biochem Tech"},{"key":"655_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovic","year":"2007","unstructured":"Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I, Ruzicka F (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891\u2013899","journal-title":"APMIS"},{"key":"655_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1574-6968.2009.01654.x","volume":"297","author":"SWJ Gould","year":"2009","unstructured":"Gould SWJ, Chadwick M, Cuschieri P, Easmon S, Richardson AC, Price RG et al (2009) The evaluation of novel chromogenic substrates for the detection of lipolytic activity in clinical isolates of Staphylococcus aureus and MRSA from two European study groups. FEMS Microbiol Lett 297:10\u201316","journal-title":"FEMS Microbiol Lett"},{"key":"655_CR43","first-page":"1823","volume":"55","author":"EJ Al-kazaz","year":"2014","unstructured":"Al-kazaz EJ, Melconian AK, Kandela NJ (2014) Extraction of Staphyloxanthin from Staphylococcus aureus isolated from clinical sources to determine its antibacterial activity against other bacteria. Iraqi J Sci 55:1823\u20131832","journal-title":"Iraqi J Sci"},{"key":"655_CR44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"655_CR45","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1126\/science.274.5294.1859","volume":"274","author":"L Song","year":"1996","unstructured":"Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE (1996) Structure of Staphylococcal \u03b1-hemolysin, a heptameric transmembrane pore. Science 274:1859\u20131865","journal-title":"Science"},{"key":"655_CR46","doi-asserted-by":"publisher","first-page":"24465","DOI":"10.1074\/jbc.M109.022624","volume":"284","author":"N Suree","year":"2009","unstructured":"Suree N, Liew CK, Villareal VA, Thieu W, Fadeev EA, Clemens JJ et al (2009) The structure of the Staphylococcus aureus sortase-substrate complex reveals how the universally conserved LPXTG sorting signal is recognized*. J Biol Chem 284:24465\u201324477","journal-title":"J Biol Chem"},{"key":"655_CR47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.str.2008.02.011","volume":"16","author":"DJ Sidote","year":"2008","unstructured":"Sidote DJ, Barbieri CM, Wu T, Stock AM (2008) Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure 16:727\u2013735","journal-title":"Structure"},{"key":"655_CR48","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1126\/science.1153018","volume":"319","author":"C-I Liu","year":"2008","unstructured":"Liu C-I, Liu GY, Song Y, Yin F, Hensler ME, Jeng W-Y et al (2008) A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319:1391\u20131394","journal-title":"Science"},{"key":"655_CR49","unstructured":"The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, LLC"},{"key":"655_CR50","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786","journal-title":"J Chem Inf Model"},{"key":"655_CR51","first-page":"175","volume":"6","author":"V Antonic","year":"2013","unstructured":"Antonic V, Stojadinovic A, Zhang B, Izadjoo MJ, Alavi M (2013) Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus. Infect Drug Resist 6:175\u2013186","journal-title":"Infect Drug Resist"},{"key":"655_CR52","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1099\/mic.0.29071-0","volume":"152","author":"K Sambanthamoorthy","year":"2006","unstructured":"Sambanthamoorthy K, Smeltzer KM, Elasri MO (2006) Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus. Microbiology 152:2559\u20132572","journal-title":"Microbiology"},{"key":"655_CR53","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.3390\/ijms19113487","volume":"19","author":"B Kot","year":"2018","unstructured":"Kot B, Sytykiewicz H, Sprawka I (2018) Expression of the biofilm-associated genes in methicillin-resistant Staphylococcus aureus in biofilm and planktonic conditions. Int J Mol Sci 19:3487","journal-title":"Int J Mol Sci"},{"key":"655_CR54","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1007\/s00253-012-4674-z","volume":"97","author":"JH Lee","year":"2013","unstructured":"Lee JH, Cho HS, Kim Y, Kim J, Banskota S, Cho MH et al (2013) Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus. Appl Microbiol Biotechnol 97:4543\u20134552. https:\/\/doi.org\/10.1007\/s00253-012-4674-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"655_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u2206\u2206CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"655_CR56","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong SYC, Authora C, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603\u2013661","journal-title":"Clin Microbiol Rev"},{"key":"655_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/toxins8030072","volume":"8","author":"C Kong","year":"2016","unstructured":"Kong C, Neoh H, Nathan S (2016) Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy. Toxins (Basel) 8:72","journal-title":"Toxins (Basel)"},{"key":"655_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrd1008","volume":"2","author":"D Davies","year":"2003","unstructured":"Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114\u2013122. https:\/\/doi.org\/10.1038\/nrd1008","journal-title":"Nat Rev Drug Discov"},{"key":"655_CR59","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1089\/adt.2019.944","volume":"17","author":"S Mujwar","year":"2019","unstructured":"Mujwar S, Deshmukh R, Harwansh RK, Gupta JK, Gour A (2019) Drug repurposing approach for developing novel therapy against mupirocin-resistant Staphylococcus aureus. Assay Drug Dev Technol 17:944","journal-title":"Assay Drug Dev Technol"},{"key":"655_CR60","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nrd940","volume":"1","author":"A Coates","year":"2002","unstructured":"Coates A, Hu Y, Bax R, Page C (2002) The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 1:895\u2013910","journal-title":"Nat Rev Drug Discov"},{"key":"655_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fcimb.2019.00074","volume":"9","author":"OF Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez OF, Cardoso MH, Ribeiro SM, Franco OL (2019) Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol 9:74. https:\/\/doi.org\/10.3389\/fcimb.2019.00074","journal-title":"Front Cell Infect Microbiol"},{"key":"655_CR62","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10096-020-03882-z","volume":"39","author":"NM Seleem","year":"2020","unstructured":"Seleem NM, Abd El Latif HK, Shaldam MA, El-Ganiny AM (2020) Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections. Eur J Clin Microbiol Infect Dis. 39:1687\u20131702. https:\/\/doi.org\/10.1007\/s10096-020-03882-z","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"655_CR63","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s00203-020-01992-y","volume":"10","author":"HA Abbas","year":"2020","unstructured":"Abbas HA, Atallah H, El-Sayed MA, El-Ganiny AM (2020) Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Arch Microbiol 10:2751\u20132760. https:\/\/doi.org\/10.1007\/s00203-020-01992-y","journal-title":"Arch Microbiol"},{"key":"655_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4314\/ahs.v17i1.25","volume":"17","author":"SA El-Mowafy","year":"2017","unstructured":"El-Mowafy SA, Abd El Galil KH, Habib ESE, Shaaban MI (2017) Quorum sensing inhibitory activity of sub-inhibitory concentrations of \u03b2-lactams. Afr Health Sci 17:199\u2013207","journal-title":"Afr Health Sci"},{"key":"655_CR65","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/AAC.5.4.420","volume":"5","author":"KHS Swamy","year":"1974","unstructured":"Swamy KHS, Sirsi M, Rao GR (1974) Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. Antimicrob Agents Chemother 5:420\u2013425","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR66","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1128\/AAC.16.5.660","volume":"16","author":"IJ Sud","year":"1979","unstructured":"Sud IJ, Chou DL, Feingold DS (1979) Effect of free fatty acids on liposome susceptibility to imidazole antifungals. Antimicrob Agents Chemother 16:660\u2013663","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR67","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.2174\/13895575113136660091","volume":"13","author":"N Rani","year":"2013","unstructured":"Rani N, Sharma A, Dahiya RS (2013) Imidazoles as promising scaffolds for antibacterial activity: a review. Mini-Rev Med Chem 13:1812\u20131835. https:\/\/doi.org\/10.2174\/13895575113136660091","journal-title":"Mini-Rev Med Chem"},{"key":"655_CR68","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1002\/slct.201904758","volume":"5","author":"K Faheem","year":"2020","unstructured":"Faheem K, Rubina A, Rukesh M, Muhammad RH, Shabana US, Khalid MK, Muhammad IM (2020) Enhanced anti-bacterial activity of non-antibacterial drug candesartan cilexetil by delivery through polymeric micelles. ChemistrySelect 5:3605\u20133612","journal-title":"ChemistrySelect"},{"key":"655_CR69","first-page":"18","volume":"61","author":"H Kruszewska","year":"2005","unstructured":"Kruszewska H, Zareba T, Tyski S (2005) Examination of antimicrobial activity of selected non-antibiotic drugs. Acta Pol Pharm 61:18\u201321","journal-title":"Acta Pol Pharm"},{"key":"655_CR70","first-page":"450","volume":"10","author":"Z Zou","year":"2017","unstructured":"Zou Z, Zhou X, Wang J (2017) Antibacterial activity of ondansetron and granisetron in vitro. Int J Clin Exp Med 10:450\u2013454","journal-title":"Int J Clin Exp Med"},{"key":"655_CR71","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1007\/s00253-019-09954-1","volume":"103","author":"H Abdel-Halim","year":"2019","unstructured":"Abdel-Halim H, Al Dajani A, Abdelhalim A, Abdelmalek S (2019) The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach. Appl Microbiol Biotechnol 103:6309\u20136318","journal-title":"Appl Microbiol Biotechnol"},{"key":"655_CR72","doi-asserted-by":"publisher","first-page":"e01296","DOI":"10.1128\/AAC.01296-18","volume":"62","author":"F D\u2019Angelo","year":"2018","unstructured":"D\u2019Angelo F, Baldelli V, Halliday N, Pantalone P, Polticelli F, Fiscarelli E et al (2018) Identification of FDA-approved drugs as anti-virulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa. Antimicrob Agents Chemother 62:e01296-1318. https:\/\/doi.org\/10.1128\/AAC.01296-18","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR73","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08927014.2015.1125888","volume":"32","author":"JH Lee","year":"2016","unstructured":"Lee JH, Kim YG, Lee K, Kim C, Park D, Ju Y et al (2016) Streptomyces-derived actinomycin D inhibits bioflm formation by Staphylococcus aureus and its hemolytic activity. Biofouling 32:45\u201356. https:\/\/doi.org\/10.1080\/08927014.2015.1125888","journal-title":"Biofouling"},{"key":"655_CR74","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4314\/ahs.v19i1.10","volume":"19","author":"HA Abbas","year":"2019","unstructured":"Abbas HA, Elsherbini AM, Shaldam MA (2019) Glyceryl trinitrate blocks staphyloxanthin and bioflm formation in Staphylococcus aureus. Afr Health Sci 19:1376\u20131384. https:\/\/doi.org\/10.4314\/ahs.v19i1.10","journal-title":"Afr Health Sci"},{"key":"655_CR75","first-page":"66","volume":"2","author":"HA Abbas","year":"2012","unstructured":"Abbas HA, Serry FM, EL-Masry EM (2012) Combating Pseudomonas aeruginosa biofilms by potential biofilm inhibitors. Asian J Res Pharm Sci 2:66\u201372","journal-title":"Asian J Res Pharm Sci"},{"key":"655_CR76","first-page":"21","volume":"2","author":"G Srividya","year":"2017","unstructured":"Srividya G, Deepthi B, Lakshminarasaiah S (2017) Ascorbic acid enhances ciprofloxacin antibacterial activity in vitro against isolates of Escherichia coli from subclinical mastitis cases of buffaloes. IJVSAH 2:21\u201324","journal-title":"IJVSAH"},{"key":"655_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.02027","volume":"10","author":"A Selvaraj","year":"2019","unstructured":"Selvaraj A, Jayasree T, Valliammai A, Pandian SK (2019) Myrtenol attenuates MRSA bioflm and virulence by suppressing sarA expression dynamism. Front Microbiol 10:1\u201315. https:\/\/doi.org\/10.3389\/fmicb.2019.02027","journal-title":"Front Microbiol"},{"key":"655_CR78","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/s41598-018-21141-2","volume":"8","author":"C Kong","year":"2018","unstructured":"Kong C, Chee C, Richter K, Thomas N, Abd. Rahman N, Nathan S (2018) Suppression of Staphylococcus aureus bioflm formation and virulence by a benzimidazole derivative, UM-C162. Sci Rep 8:2758. https:\/\/doi.org\/10.1038\/s41598-018-21141-2","journal-title":"Sci Rep"},{"key":"655_CR79","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3389\/fmicb.2019.01557","volume":"10","author":"N Tharmalingam","year":"2019","unstructured":"Tharmalingam N, Khader R, Fuchs BB, Mylonakis E (2019) The anti-virulence efficacy of 4-(1,3-dimethyl-2,3-dihydro-1H-benzimidazol-2-yl)phenol against methicillin-resistant Staphylococcus aureus. Front Microbiol 10:1557. https:\/\/doi.org\/10.3389\/fmicb.2019.01557","journal-title":"Front Microbiol"},{"key":"655_CR80","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/jam.14968","volume":"131","author":"AA Abdelaziz","year":"2020","unstructured":"Abdelaziz AA, El-Barrawy MA, El-Nagar RAM (2020) Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study. J Appl Microbiol 131:182\u2013196. https:\/\/doi.org\/10.1111\/jam.14968","journal-title":"J Appl Microbiol"},{"key":"655_CR81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nchembio.2003","volume":"12","author":"F Chen","year":"2016","unstructured":"Chen F, Di H, Wang Y, Cao Q, Xu B, Zhang X et al (2016) Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence. Nat Chem Biol 12:174","journal-title":"Nat Chem Biol"},{"key":"655_CR82","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1099\/jmm.0.047316-0","volume":"62","author":"S Leejae","year":"2013","unstructured":"Leejae S, Hasap L, Voravuthikunchai SP (2013) Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate. J Med Microbiol 62:421\u2013428. https:\/\/doi.org\/10.1099\/jmm.0.047316-0","journal-title":"J Med Microbiol"},{"key":"655_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4172\/2167-7689.1000126","volume":"3","author":"O Cho","year":"2014","unstructured":"Cho O, Shiokam T, Ando Y, Aoki N, Uehara C, Maeda E, Matsumoto S, Kurakado S, Sugita T (2014) Screening of compounds from an FDA-approved drug library for the ability to inhibit aspartic protease secretion from the pathogenic yeast Candida albicans. Pharmaceut Reg Affairs 3:5. https:\/\/doi.org\/10.4172\/2167-7689.1000126","journal-title":"Pharmaceut Reg Affairs"},{"key":"655_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.sdentj.2020.01.008","volume":"33","author":"M Zainal","year":"2021","unstructured":"Zainal M, Zain NM, Amin IM, Ahmad VN (2021) The antimicrobial and antibiofilm properties of allicin against Candida albicans and Staphylococcus aureus \u2013 A therapeutic potential for denture stomatitis. The Saudi Dent J 33:105\u2013111. https:\/\/doi.org\/10.1016\/j.sdentj.2020.01.008","journal-title":"The Saudi Dent J"},{"key":"655_CR85","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1128\/IAI.71.7.4206-4211.2003","volume":"71","author":"KE Beenken","year":"2003","unstructured":"Beenken KE, Blevins JS, Smeltzer MS (2003) Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun 71:4206\u20134211","journal-title":"Infect Immun"},{"key":"655_CR86","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1128\/jb.182.24.6983-6991.2000","volume":"182","author":"S Gertz","year":"2000","unstructured":"Gertz S, Engelmann SS, Schmid R, Ziebandt A, Tischer K, Scharf C et al (2000) Characterization of the \u03c2B Regulon in Staphylococcus aureus. J Bacteriol 182:6983\u20136991. https:\/\/doi.org\/10.1128\/jb.182.24.6983-6991.2000","journal-title":"J Bacteriol"},{"key":"655_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1389450117666161128123536","volume":"19","author":"TL Kane","year":"2018","unstructured":"Kane TL, Carothers KE, Lee SW (2018) Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics. Curr Drug Targets 19:111\u2013127. https:\/\/doi.org\/10.2174\/1389450117666161128123536","journal-title":"Curr Drug Targets"},{"key":"655_CR88","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/1348-0421.12377","volume":"60","author":"M Murai","year":"2016","unstructured":"Murai M, Moriyama H, Hata E, Takeuchi F, Amemura-Maekawa J (2016) Variation and association of fibronectin-binding protein genes fnbA and fnbB in Staphylococcus aureus Japanese isolates. Microbiol Immunol 60:312\u2013325","journal-title":"Microbiol Immunol"},{"key":"655_CR89","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s12879-018-3457-2","volume":"18","author":"O Haddad","year":"2018","unstructured":"Haddad O, Merghni A, Elargoubi A, Rhim H, Kadri Y, Mastouri M (2018) Comparative study of virulence factors among methicillin resistant Staphylococcus aureus clinical isolates. BMC Infect Dis 18:560","journal-title":"BMC Infect Dis"},{"key":"655_CR90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcimb.2012.00038","volume":"2","author":"D Cue","year":"2012","unstructured":"Cue D, Lei MG, Lee CY (2012) Genetic regulation of the intercellular adhesion locus in Staphylococci. Front Cell Infect Microbiol 2:38","journal-title":"Front Cell Infect Microbiol"},{"key":"655_CR91","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/mr.55.4.733-751.1991","volume":"55","author":"S Bhakdi","year":"1991","unstructured":"Bhakdi S, Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55:733\u2013751","journal-title":"Microbiol Rev"},{"key":"655_CR92","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1128\/AAC.00269-13","volume":"57","author":"V Khodaverdian","year":"2013","unstructured":"Khodaverdian V, Pesho M, Truitt B, Bollinger L, Patel P, Nithianantham S et al (2013) Discovery of anti-virulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57:3645\u20133652. https:\/\/doi.org\/10.1128\/AAC.00269-13","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR93","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1128\/AAC.00834-16","volume":"60","author":"AS Hendrix","year":"2016","unstructured":"Hendrix AS, Spoonmore TJ, Wilde AD, Putnam NE, Hammer ND, Snyder DJ et al (2016) Repurposing the non-steroidal anti-infammatory drug difunisal as an osteoprotective, antivirulence therapy for Staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother 60:5322\u20135330. https:\/\/doi.org\/10.1128\/AAC.00834-16","journal-title":"Antimicrob Agents Chemother"},{"key":"655_CR94","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/jam.14543","volume":"128","author":"YQ Mu","year":"2020","unstructured":"Mu YQ, Xie TT, Zeng H, Chen W, Wan CX, Zhang LL (2020) Streptomyces-derived actinomycin D inhibits bioflm formation via downregulating ica locus and decreasing production of PIA in Staphylococcus epidermidis. J Appl Microbiol 128:1201\u20131207. https:\/\/doi.org\/10.1111\/jam.14543","journal-title":"J Appl Microbiol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-021-00655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-021-00655-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-021-00655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T10:47:42Z","timestamp":1699786062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-021-00655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s42770-021-00655-4","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,13]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The paper does not contain any study on human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}